Estimated Number of Aesthetic Medical and AGA Treatment Users in the Past Year Reaches 1.95 Million – Visualizing the Reality of Private Medical Care Invisible in Public Data

Intage Healthcare Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; President and CEO: Keita Murai) conducted a self-initiated survey targeting approximately 55,000 men and women aged 20–50 across Japan. The purpose was to understand the actual state of 'private medical care (non-insurance-covered treatments),' a field of growing interest that is difficult to fully grasp using public data alone. This survey collected data on the number of users within the past year, treatment-seeking behaviors, usage channels, and spending amounts, aiming to understand the private medical care market from the consumer's perspective. Based on the results, the company also conducted its own market size estimations for each field.

This report focuses on two areas: 'aesthetic medical care (face/skin) (※1)' and 'AGA (※2) treatment.' As part of the findings, we present the estimated number of users in the past year for each field, consumer actions from recognizing a concern to receiving treatment, and the status of online consultation usage.

※1 Treatments targeting the face and skin, including pigmentation removal and skin-beautifying lasers, medical HIFU, Botox injections, skin-nourishing injections, hyaluronic acid and other injectables, Dermapen, Potenza, thread lifts, and double eyelid surgery.

※2 Androgenetic Alopecia: Male pattern baldness

【Key Points】

- Estimated number of aesthetic medical (face/skin) users in the past year: approx. 1.22 million; AGA treatment users: approx. 730,000 - While many people suffer from skin or hair thinning concerns, the one-year experience rate for private medical care remains limited - For AGA treatment, online consultations have become a primary channel, making the reliability and safety of information critically important

1. Estimated number of users in the past year: approx. 1.22 million for aesthetic medical (face/skin) care and approx. 730,000 for AGA treatment

【Base】Individuals among nationwide men and women aged 20–50 (n=54,832) who experienced each private medical treatment within the past year

Based on the survey results, we estimated the number of users in each field over the past year (※3). The number of users for aesthetic medical (face/skin) care was estimated at approximately 1.22 million, and for AGA treatment at approximately 730,000. Aesthetic medical (face/skin) care includes treatments such as pigmentation removal lasers, Botox, and double eyelid surgery, targeting the face and skin, and represents a field with a broad user base. In contrast, AGA treatment shows a certain scale of users, primarily among men.

※3 These figures are proprietary estimates by our company based on survey data and may include effects such as non-response bias.

2. The robust alternative market of 'self-care and non-medical services' and the rise of online consultations

【Base】Nationwide men and women aged 20–50 (n=54,832) ※Weighted back-calculated values adjusted to match the gender and age composition of the population

Next, we compared the proportion of people suffering from symptoms in each field with the one-year experience rate. While 59.9% of respondents reported skin concerns, the one-year experience rate for aesthetic medical (face/skin) care was only 2.0%. Similarly, while 22.0% reported concerns about thinning hair or hair loss, the experience rate for AGA treatment was only 1.2%.

This gap suggests the existence of a robust alternative market in 'self-care and non-medical services' such as supplements, over-the-counter medications, cosmetics, and hair growth products.

【Base】Users of each private medical treatment within the past year (aesthetic medicine n=598, AGA treatment n=215) ※Weighted back-calculated values (multiple responses allowed)

Regarding usage channels, for aesthetic medical (face/skin) care, major chains of cosmetic surgery and dermatology clinics accounted for 49.8%, and general clinics and hospitals for 39.1%, indicating that in-person treatment remains central. In contrast, for AGA treatment, online consultations were the most frequently used channel at 43.6%, making it the primary access point. As online consultations expand, it becomes crucial during the treatment consideration and selection phase to ensure and appropriately present not just convenience, but also the reliability, effectiveness, and safety (e.g., side effect risks) of the information provided.

【Insights】

From this survey, we infer that for aesthetic medical (face/skin) care, which has the largest user base, experience value and trust design based on ongoing and multiple treatments are essential. For AGA treatment, usage is increasingly starting online, making the assurance of diagnostic quality, information reliability, and safety—not just price and convenience—a key issue.

For both fields, the key to building a healthy environment going forward lies in providing accurate information for 'appropriate use' to the latent population currently relying on non-medical self-care, and in establishing safe treatment pathways based on social ethics.

Tamura Senya, Healthcare Marketing Division 1, Marketing & Value Insights Business Unit

Overview of the Private Medical Care Market Research Report

Survey Name

Private Medical Care Market Research Report

Survey Purpose

Comprehensive understanding of the market size and actual usage of private medical care

Survey Target

Men and women aged 20–59 across Japan

Screening Survey: 54,832 respondents

Main Survey: 995 respondents

Survey Period

December 19–24, 2025

Survey Method

Internet survey

Survey Conducted by

Intage Healthcare Co., Ltd.

This report provides detailed analysis of data useful for business planning, including 'patient journeys for each treatment,' 'decision points for continuation or switching,' and 'impact on the skincare market after aesthetic medical treatments,' in addition to spending amounts and market size estimates for each field. The detailed table of contents and a 'sample report' excerpting selected data can be downloaded from the link below.

Sample Report: https://www.intage-healthcare.co.jp/download/cosmetic_sample/

[Intage Healthcare Co., Ltd.] https://www.intage-healthcare.co.jp/

Intage Healthcare Co., Ltd. positions marketing research and data science services in the medical and healthcare fields as its core business. Working in collaboration with other companies within the Intage Group that specialize in healthcare, it provides solutions through data analysis and utilization. The company supports optimal decision-making for various challenges in the healthcare sector by leveraging data value from the perspective of 'medical consumers.'

※ Kyowa Kikaku Co., Ltd., Intage Realworld Co., Ltd., Plamed Co., Ltd., Plamed Korea Co., Ltd.

[About the Intage Group] https://www.intageholdings.co.jp/

(Tokyo Stock Exchange Prime Market, Stock Code: 4326)

Since its founding in 1960, the Intage Group has collected, processed, and analyzed diverse data, adding unique insights to deliver value to clients and support their decision-making. As a partner to clients, the group addresses their 'questions' by integrating consumer understanding with technology to guide the 'next step.'

【Inquiries regarding this survey】

Intage Healthcare Co., Ltd.

Marketing & Value Insights Business Unit, Healthcare Marketing Division 1

Tamura

TEL: 03-5294-8393 (main)

E-mail: ihc-hcf-marketing@intage.com

【Media inquiries】

Intage Healthcare Co., Ltd.

Corporate Planning Department, Public Relations

Fukaya

TEL: 03-5294-8393 (main)

E-mail: pr-ihc@intage.com